Efficacy of enzalutamide in subgroups of men with metastatic hormone-sensitive prostate cancer based on prior therapy, disease volume, and risk

DSpace Repository

Efficacy of enzalutamide in subgroups of men with metastatic hormone-sensitive prostate cancer based on prior therapy, disease volume, and risk

Author: Azad, Arun A.; Armstrong, Andrew J.; Alcaraz, Antonio; Szmulewitz, Russell Z.; Petrylak, Daniel P.; Holzbeierlein, Jeffrey; Villers, Arnauld; Alekseev, Boris; Iguchi, Taro; Shore, Neal D.; Gomez-Veiga, Francisco; Rosbrook, Brad; Lee, Ho-Jin; Haas, Gabriel P.; Stenzl, Arnulf
Tübinger Autor(en):
Stenzl, Arnulf
Published in: Prostate Cancer and Prostatic Diseases (2022), Bd. 25, H. 2, S. 274-282
Verlagsangabe: Springernature
Language: English
Full text: http://dx.doi.org/10.1038/s41391-021-00436-y
ISSN: 1365-7852
DDC Classifikation: 610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)